Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

News Conference News ACC 2026

GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food as Medicine’

L.A. McKeown

March 31, 2026

Presentation ACC 2026

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Presenter: Shao-Liang Chen

March 30, 2026

Presentation ACC 2026

THRIVE Food is Medicine Pilot Trial

Presenter: Oluwabunmi Ogungbe

March 30, 2026

News Conference News ACC 2026

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

Todd Neale

March 29, 2026

Presentation ACC 2026

Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study

Presenter: Mardi Gomberg-Maitland

March 29, 2026

News Conference News ACC 2026

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

Caitlin E. Cox

March 28, 2026

Presentation ACC 2026

Groceries for Black Residents of Boston to Stop Hypertension among Adults with Treated Hypertension (GoFreshRx)

Presenter: Stephen Paul Juraschek

March 28, 2026

Presentation ACC 2026

KARDINAL: Efficacy and Safety of Tonlamarsen in Patients with Uncontrolled Hypertension

Presenter: Luke Laffin

March 28, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

Presentation ACC 2025

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Presenter: Luke Laffin

March 29, 2025

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

L.A. McKeown

April 16, 2024

News Conference News ACC 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Shelley Wood

April 11, 2024

Presentation ACC 2024

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

Presenter: David E. Kandzari

April 08, 2024

Presentation ACC 2024

Primary Results from the Phase 2 KARDIA-2 Study

Presenter: Akshay Desai

April 07, 2024

News Conference News ACC 2024

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

Caitlin E. Cox

April 06, 2024

Presentation ACC 2024

Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk

Presenter: Ronald Chi Hang Lee

April 06, 2024

News Conference News ACC 2024

Lack of Sleep Ups Hypertension Risk, Especially for Women

Yael L. Maxwell

April 03, 2024

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Conference News ACC 2023

Keto Diet Linked to Hypercholesterolemia, Higher ASCVD Risk

Shelley Wood

March 08, 2023

News Conference News ACC 2023

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

Todd Neale

March 08, 2023

Advertisement

GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food as Medicine’

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

THRIVE Food is Medicine Pilot Trial

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

Groceries for Black Residents of Boston to Stop Hypertension among Adults with Treated Hypertension (GoFreshRx)

KARDINAL: Efficacy and Safety of Tonlamarsen in Patients with Uncontrolled Hypertension

What’s Going to Be Hot at ACC 2026

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

Primary Results from the Phase 2 KARDIA-2 Study

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk

Lack of Sleep Ups Hypertension Risk, Especially for Women

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Keto Diet Linked to Hypercholesterolemia, Higher ASCVD Risk

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content